New article! Metabolaid and its effect on satiety

We are happy to announce that a scientific peer-reviewed article on Metabolaid has been recently published in the journal Food and Function.

Continue reading New article! Metabolaid and its effect on satiety

Vitafoods Europe: success of novelties and digitalization

Vitafoods Europe was held two weeks ago in Geneva, specifically in Palexpo. Although the results of the fairs of ingredients of the nutraceutical industry are always seen in the medium and long term, we can consider this trade show as very positive for Monteloeder.

Continue reading Vitafoods Europe: success of novelties and digitalization

 Special Report on Personalized Nutrition for NutritionInsight.com

This special report is a collaboration with Nutrition Insight where Marcos López, Brand Manager of Monteloeder and our specialist in the subject of Digitalization, talks about personalized nutrition and technology.
Here you can read the full article.

Continue reading  Special Report on Personalized Nutrition for NutritionInsight.com

Monteloeder’s Digital Health solution for obesity: Metabolaid

Monteloeder has coined the concept of “Digital Nutraceutical”, which combines food & nutrition supplements with digital technology, resulting in a complete, personalized health solution.

Continue reading Monteloeder’s Digital Health solution for obesity: Metabolaid

Monteloeder at Vitafoods Europe

Monteloeder is once again present in this edition of Vitafoods Europe, The global nutraceutical event, on May 15th – 17th. Do not miss this event that will take place at the Palexpo, Geneva, Switzerland.

Continue reading Monteloeder at Vitafoods Europe

Personalization in healthcare: solution for the “holistically effective” approach

Today I came across with 2 studies published in high-impact factor journals [Cell group] giving opposite messages regarding the use of dietary supplements, due to unexpected interactions and influences on health conditions.

Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging

– A positive effect of Nicotinamide mononucleotide (NMN), a molecule used in supplements for active aging since many years, on improving blood vessels functionality of old mice (comparable to 70-year-old humans), being a decline in capillary density and blood flow a major cause of mortality and morbidity. Interestingly, the molecular mechanism behind (that increased levels of the anti-aging enzyme SIRT1) is similar to workout and dietary restriction

The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells

– A negative effect of chondroitin-4-sulfate (CHSA), a natural glycosaminoglycan approved as a dietary supplement used for osteoarthritis, that selectively promotes the tumor growth of melanoma cells containing a specific genetic characteristic (mutation V600E of the gene BRAF) which is present in around 50% of melanomas. Not only this, it seems that it confers drug resistance to a commonly used anti-melanoma therapy (BRAF inhibitors).

Of course, these are only two examples of many studies regarding the (sometimes unpredicted) interactions between the use of supplements and health/disease conditions unrelated to their first indications. Dietary supplements contain a variety of ingredients, both natural herbal/botanicals and other categories (such as vitamins, minerals, amino acids), and in any case, it is important to understand their effects and effectiveness, because “natural” does not always mean “harmless” and “safe”1. It is actually very important to understand the label instructions, follow the healthcare providers advice (and tell them about any supplement you are taking) and trust only products with clear label statements and only from trusted manufacturers.

In the pursuit of effectiveness and safety, the healthcare trend towards Personalization will be relevant also in the Supplements field where an accurate and solid scientific background is necessary and must be always kept in mind along any step of product design and buyer journey. Indeed, a more comprehensive approach that takes into account not only the properties of any ingredient but also the eventual effects in different contexts is the safest and effective solution.

For example, as in the case of CHSA dangerous effect for a specific group of cancer patients, Genotype is an important piece of information to be considered to personalize both therapeutic treatments and dietary advice. However, it is reasonable to look for genetic information only if the “Biological plausibility” could apply: “a gene–environment interaction will only be accepted if it can be reproduced in two or more studies and also seems plausible at the biological level” [https://bit.ly/2pFwdjM]

The success of any Personalization approach resides in the use of a combination of any relevant information, as personal characteristics (genetics, age, anthropometrics, health status, family history) and context information, and never prioritizes any of them in isolation. I am confident that many relevant success stories, based on Personalization in wellbeing and healthcare, are coming and each one of us will be witness or main player in one or many of them!

Note 1: Easy-to-access basic information regarding dietary supplements could be found here and here (respectively from the US and European official Authorities websites).

Elisa Guida, PhD

Brand and Account Manager

Stay fit, Eat well

In an article from Malaysia local newspaper, 13.3 percent of the population is facing obesity while 38.5 percent are considered overweight. Bad dietary habit is the root cause of this problem. If one is looking closer to a very typical meals options for individual, it is not difficult to understand why.

Continue reading Stay fit, Eat well

VITAFOODS EUROPE: Editor’s Award for Innovation

We are pleased to announce that Monteloeder has been nominated as Finalist in the “Editor’s Award for Innovation” for the Nutraingredients Awards in Vitafoods Europe, held in Geneva on May 15-17. Over 20,000 attendees are expected to visit the meeting, making it one of the largest in Europe.

Besides exhibiting, we will provide a presentation for the award entitled: “Digital Nutraceutics, the Paradigm Shift: Metabolaid; a Case Study.” Here, we will explain Monteloeder’s digitalization approach in the nutraceutical sector. Monteloeder is quickly becoming a reference in digital health, with products that are currently available combining supplementation and digitization, such as Nutroxsun and more recently Metabolaid. Specifically, Metabolaid will be presented in the meeting, which is an ingredient that has been clinically proven to help consumers lose weight by helping them control their appetite.

The winners of the awards will be announced on May 16th, during the Awards Dinner.

We thank Vitafoods Europe for our candidacy to the Award. Hope to see you there!

MetabolAid: H2020 project, instrument between Monteloeder and the UCAM

The last day January 22nd, an agreement was signed for the clinical trial of the MetabolAid H2020 project, an SME instrument between Monteloeder and the Universidad Católica de Murcia (UCAM).

Continue reading MetabolAid: H2020 project, instrument between Monteloeder and the UCAM

Project EU H2020: MetabolAid with a distinction granted by the European Commission

Yesterday, Monteloeder presented at a press conference at the University Miguel Hernandez in Elche, the distinction granted by the European Commission (project EU_H2020) for the launching and marketing MetabolAid, an ingredient that provides the solution for Metabolic Syndrome.

Monteloeder would like to thank Mr. Marco Cecchetto (Project Adviser European Commission); Magnífico Mr. D. Jesús Tadeo Pastor (Rector of the UMH); Mr. Manuel Jordá (Vice-rector for Investigation and Innovation of the UMH);  and Sr. Vicente Micol (Vice-rector for International Relations of the UMH) for assisting to the press conference.

In addition, the owner of a business Monteloeder, Sr. Ignacio Cartagena and Arturo Lizón Ph.D. (CEO of Monteloeder), as representatives of the company.

Moreover, we would like to thank the media support because we had a massive participation of the mass media, which picked the story up:

DAILY NEWSPAPER

-Diario ABC: La CE avala un ingrediente natural para regular el peso en personas obesas producido en Elche

-Diario Información: Un freno natural contra la obesidad

-Alicante Plaza: La Empresa ilicitana Monteloeder, financiada por la Comisión Europea por su innovación en salud.

-La Vanguardia: Empresa de Elche comercializará ingrediente natural ante síndrome metabólico

TV

-Tele Elx: Una empresa ilicitana recibe un millón de euros de la Comisión Europea

-Telecinco: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

-Cuatro: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

FINANCIAL PRESS

-Bolsamania: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

-El Economista: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

AGENCY

-Europa Press: La CE selecciona una empresa de Elche para comercializar un ingrediente que controla el apetito

HEALTH

-Infosalus: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

DIGITAL MEDIA

-20 minutos: La CE selecciona una empresa de Elche para comercializar un ingrediente que controla el apetito

-Diario Siglo XXI: Monteloeder recibe una ayuda de la Comisión Europea para comercializar a nivel europeo ‘MetabolAid’

-Gente Digital: La CE selecciona una empresa de Elche para comercializar un ingrediente que controla el apetito

UNIVERSITIES

-UMH: La UMH participa en el estudio del ingrediente natural “MetabolAid” que aumenta la sensación de saciedad y que avala la Comisión Europea

-RUVID: La UMH participa en el estudio del ingrediente natural MetabolAid

OVERVIEW OF THE PRESS CONFERENCE